Also listed on Axelia Oncology Pty Ltd., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Aug 17, 2040 · Medium confidence
20-year base term ends Jun 26, 2040
Why Medium: The disclaimer's references carry disclaimers of their own not yet read (US 12,017,979), so the cap could be lower.
Jun 26, 2020
Aug 17, 2040
Aug 18, 2026
This patent's term runs 954 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 0 of 3 maintenance fees are paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jun 26, 2020, when application PCT/AU2020/050660, the earliest non-provisional in its chain, was filed (this one was filed Dec 23, 2021) | Jun 26, 2040 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +954 days, USPTO patent term adjustment record | Feb 5, 2043 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 12,017,979) | capped to Aug 17, 2040 | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 0 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 17, 2040 | Medium confidence |
Partial family
| Application PCT/AU2020/050660 | PCT application no patent term | no patent term |
| US 12,709,596 | this patent Aug 2040 | Aug 2040 |
| US 12,017,979 | In force no later than Aug 2040 | no later than Aug 2040 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 24, 2022 Reel 60001, frame 9 | McLachlan, Grant | Axelia Oncology Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61140, frame 372 | Jackson, David | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61140, frame 468 | Holmes, Ian | BCP3 Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61140, frame 533 | BCP3 Pty Ltd. | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61140, frame 747 | Demaison, Christophe | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61140, frame 840 | The University of Melbourne | Ena Therapeutics Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61141, frame 16 | Axelia Oncology Pty Ltd. | Ena Respiratory Pty Ltd. | Assignment of Assignor's Interest |
| Sep 19, 2022 Reel 61468, frame 822 | Zeng, Weiguang | The University of Melbourne | Assignment of Assignor's Interest |
| Sep 20, 2022 Reel 61481, frame 222 | Ena Therapeutics Pty Ltd. | Axelia Oncology Pty Ltd. | Change of Name |
| Feb 21, 2023 Reel 62814, frame 344 | Axelia Oncology Pty Ltd. | Ena Respiratory Pty Ltd. | Confirmatory Assignment Deed |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 12,017,979.